Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Pol J Pharmacol Pharm ; 33(4): 467-74, 1981 Nov.
Article in English | MEDLINE | ID: mdl-7036117

ABSTRACT

Intraventricular injection of prostacyclin (PGI2) slightly depressed the general behavior and produced a weak hypothermia in rats. It shortened the response to a thermal nociceptive stimulus and intensified catalepsy caused by chloropromazine and haloperidol. PGI2 did not change concentration of noradrenaline, 4-hydroxytryptamine, 5-hydroxyindoleacetic acid and dopamine in different brain areas. It markedly lowered blood pressure and increased respiration. The duration of central hypotensive effect of PGI2 was shortened after 6-hydroxydopamine on 5,6-dihydroxytryptamine pretreatment. The possible involvement of a central mechanism in the hypotensive action of PGI2 requires further clarification.


Subject(s)
Behavior, Animal/drug effects , Blood Pressure/drug effects , Epoprostenol/pharmacology , Prostaglandins/pharmacology , Animals , Biogenic Amines/metabolism , Epoprostenol/administration & dosage , Heart Rate/drug effects , Injections, Intraventricular , Male , Nociceptors/drug effects , Rats , Rats, Inbred Strains , Respiration/drug effects
2.
Pol J Pharmacol Pharm ; 33(5): 481-4, 1981.
Article in English | MEDLINE | ID: mdl-7335552

ABSTRACT

Rats were treated for 14 or 30 days with 10 mg/kg sc atropine (AT) daily. 24 h after the last dose of At, 50 micrograms of muscarine (MU) was injected intracerebroventricularly (ivtr.). Long-term atropinization enhanced the behavior induced by MU. These data support our previous suggestion that chronic blockade of central muscarinic receptors induces their hypersensitivity.


Subject(s)
Atropine/pharmacology , Behavior, Animal/drug effects , Muscarine/pharmacology , Animals , Drug Synergism , Injections, Intraventricular , Male , Rats , Rats, Inbred Strains , Time Factors
3.
Psychopharmacology (Berl) ; 64(3): 337-40, 1979 Sep.
Article in English | MEDLINE | ID: mdl-116277

ABSTRACT

Rats were treated with a single dose of atropine (AT) at 5 mg/kg, or every day for 14 or 31 days with the same dose of AT, 3 h after the single dose and 24 h after the last dose of chronically administered AT, 10 micrograms of ACh was injected intracerebroventricularly, and two tests were used to examine the behavior of the animals. The tremorigenic effect of oxotremorine was also measured in mice treated with 10 mg/kg of AT for 1 month. It was shown that a single dose of AT antagonized ACh-induced behavior. The long-term treatment with AT enhanced the depressive-behavior of ACh in rats and the tremorigenic effect of oxotremorine in mice. The results suggest that long-term blockade of central cholinergic receptors induces their hypersensitivity.


Subject(s)
Atropine/pharmacology , Receptors, Cholinergic/drug effects , Acetylcholine/pharmacology , Animals , Behavior, Animal/drug effects , Dose-Response Relationship, Drug , Male , Motor Activity/drug effects , Oxotremorine/pharmacology , Rats , Time Factors , Tremor/chemically induced
4.
Psychopharmacology (Berl) ; 59(3): 273-7, 1978 Dec 08.
Article in English | MEDLINE | ID: mdl-104331

ABSTRACT

The possibility that polyphloretin phosphate (PPP) antagonizes the central effects elicited by prostaglandin (PG) E2 and F2alpha was investigated. PPP was administered i.c.v. to male Wistar rats (10 or 25 microgram) 10 or 30 min before i.c.v. injection of PGF2 or PGF2alpha (1 or 10 microgram). The duration of several component of behavior, the degree of irritability, and the rectal temperature of rats were measured; the levels of noradrenaline, dopamine, 5-hydroxytryptamine, and 5-hydroxyindoleacetic acid were measured spectrophoto-fluorometrically in discrete brain areas. PPP antagonized temperature and behaviroal changes induced in rats by PGF2alpha, but not those induced by PGE2. The magnitude of antagonism depended on the dose of PPP and on the time of the pretreatment before PGF2alpha administration. Changes in the level of biogenic amines in discrete brain areas evoked by PGs were not affected by PPP. We found that PPP antagonizes the central effects of PGF2alpha but not those of PGE2, and that changes of biogenic amines in discrete brain areas elicited by PGs are not specific.


Subject(s)
Brain/drug effects , Phloretin/analogs & derivatives , Polyphloretin Phosphate/pharmacology , Prostaglandins E/pharmacology , Prostaglandins F/pharmacology , Animals , Behavior, Animal/drug effects , Biogenic Amines/metabolism , Body Temperature/drug effects , Brain/metabolism , Dopamine/analysis , Hydroxyindoleacetic Acid/analysis , Male , Norepinephrine/analysis , Rats , Serotonin/analysis
5.
Pol J Pharmacol Pharm ; 30(5): 639-46, 1978.
Article in English | MEDLINE | ID: mdl-35782

ABSTRACT

Prostaglandins (PGs) E1, E2, F2alpha injected intracerebroventricularly (icv) in rats, potentiated chlorpromazine (CPZ) and pimozide (PI) catalepsy similarly. Cataleptogenic effect of haloperidol (HL) was potentiated specifically be PGE2. These phenomena were diminished by apomorphine (AP). Phenoxybenzamine (PB) diminished the potentiating effect of PGE2 and PGF2alpha on CPZ catalepsy, and strongly inhibited PGE2 the potentiating effect on HL and on PI catalepsy. Propranolol (PN) diminished the potentiating effect on HL and on PI catalepsy. Propranolol PN) diminished potentiating effect of PG on HL catalepsy and increased this effect of PGE1 on PI catalepsy. All examined PG induced catalepsy only when given in high doses (50 or 100 microgram icv). Cataleptogenic effect of PGE2 and PGF2 but not of PGE1, was evidently inhibited by AP. PGS inhibited AP stereotypy. The results suggest that the central dopaminergic receptors blockade is involved in the mechanism of potentiation of neuroleptic induced catalepsy by PGs, and that PGs are similar to neuroleptics in some aspects of central action.


Subject(s)
Antipsychotic Agents/pharmacology , Catalepsy/chemically induced , Prostaglandins/pharmacology , Animals , Apomorphine/pharmacology , Chlorpromazine/pharmacology , Drug Synergism , Haloperidol/pharmacology , Humans , Male , Phenoxybenzamine/pharmacology , Pimozide/pharmacology , Propranolol/pharmacology , Rats , Stereotyped Behavior/drug effects
6.
Psychopharmacology (Berl) ; 50(1): 73-80, 1976 Oct 20.
Article in English | MEDLINE | ID: mdl-827766

ABSTRACT

The aim of this paper is to examine if central chemical sympathectomy induced by two injections of 6-hydroxydopamine (6-OHDA) in a dose of 250 mug intracerebroventricularly (i.c.v.) affects behavioral phenomena elicited by apomorphine (AP) (1 or 1.2 mg/kg i.p.) or clonidine (CL) (0.1 MG/KG, 5 Or 1 mug/kg i.p.). Experiments were carried out on male Wistar rats. The time of duration of several components of behavior and the degree of irritability of rats were measured. Moreover, open field and hole test were performed. The lower dose of AP did not affected behavior of rats. The higher dose increased the locomotor and exploratory activity of animals. 6-OHDA potentiated these effects of AP. CL (0.1 mg/kg) had a depressive effect on the rats' behavior, which was potentiated by 6-OHDA. CL (5 mug/kg) had no effect on the rats' behavior, but in a dose of 1 mug/kg caused excitatory behavior. This type of behavior was abolished by 6-OHDA. In conclusion, central chemical sympathectomy caused increased sensitivity of the central nervous system on AP. Excitatory behavioral effects of CL in low dosage may be connected with stimulation of central adrenergic receptors. Depressive behavioral effect of CL in high dosage is unspecific. Central chemical sympathectomy affects by different methods the reactivity of dopaminergic and noradrenergic neurons.


Subject(s)
Apomorphine/pharmacology , Behavior, Animal/drug effects , Clonidine/pharmacology , Hydroxydopamines/pharmacology , Animals , Brain/metabolism , Dopamine/metabolism , Drug Interactions , Exploratory Behavior/drug effects , Male , Motor Activity/drug effects , Norepinephrine/metabolism , Rats
7.
Pol J Pharmacol Pharm ; 28(5): 411-21, 1976.
Article in English | MEDLINE | ID: mdl-1012972

ABSTRACT

In male Wistar rats PGF2alpha or PGE1 were injected intracerebroventricularly (icv) in a dose of 1 or 10 mug. Immediately or 1 hr after injection the locomotor and exploratory activity were measured. The levels of noradrenaline (NA), dopamine (DA) 5-hydroxytryptamine (5-HT), 5-hydroxyindoleacetic acid (5-HIAA) and acetylcholine (Ach) were measured in discrete brain areas. Both PGs applied ivc caused the depression of locomotor and exploratory activity in rats. PGE1 acted longer. Both substances but PGE1 more intensively affected the level of estimated biogenic amines in different brain structures. It is concluded that PGF2alpha and E1 are central nervous depressants. Both PGs affect neurons producing NA or 5-HT or Ach in discrete areas of brain in different manner. There is different susceptibility of brain structures on PGs action.


Subject(s)
Behavior, Animal/drug effects , Brain Chemistry/drug effects , Prostaglandins E/pharmacology , Prostaglandins F/pharmacology , Acetylcholine/metabolism , Animals , Dopamine/metabolism , Exploratory Behavior/drug effects , Hydroxyindoleacetic Acid/metabolism , Injections, Intraventricular , Male , Motor Activity/drug effects , Norepinephrine/metabolism , Prostaglandins E/administration & dosage , Prostaglandins F/administration & dosage , Rats , Serotonin/metabolism , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...